Form 4: Zivo Bioscience Director Nola E. Masterson Corrects Beneficial Ownership in Form 4 Filing

Nola E. Masterson, a director of Zivo Bioscience, Inc., filed an amended Form 4 to correct the number of common stock shares beneficially owned, adjusting the total to 122,024 shares after a transaction on June 11, 2024.

Summary

• On June 13, 2024, Nola E. Masterson, a director of Zivo Bioscience, Inc., filed an amended Form 4 with the SEC.
• This filing corrects a previous Form 4 filed on June 6, 2024, which inadvertently included an additional 66 shares of common stock.
• The corrected filing reports that Masterson beneficially owns 122,024 shares of Zivo Bioscience common stock following a transaction on June 11, 2024.
• The transaction on June 11, 2024, involved the acquisition of 6,273 shares at $0 per share.
• Masterson directly owns these shares.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it reflects transparency.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and 10% owners) to report transactions in their company's securities to the SEC, ensuring transparency and preventing insider trading.

Key Dates

Keywords

Form 4, Zivo Bioscience, Beneficial Ownership, Nola E. Masterson, Common Stock, SEC Filing